Ticlovas 250Mg Tablet

Ticlovas 250Mg Tablet is a platelet aggregation inhibitor. It reduces risk of stroke and blood clots in patients by thinning the blood. The most serious side effects of this drug are those that affect the blood cells. This may be a life-threatening side effect but rarely occurs in people. The most common side effects include diarrhoea, nausea, dyspepsia, rash, abdominal pain and increase in cholesterol, liver enzymes, triglycerides and bleeding.

The use of Ticlovas 250Mg Tablet is contraindicated in anyone with an increased risk of bleeding, a history of haematological disease, severe liver disease, a history of allergic reaction to this group of medicines. Because of the increased risk of bleeding, patients taking Ticlovas 250Mg Tablet should discontinue the medication about 10–14 days before a surgery. If you are pregnant or breastfeeding, discuss with your doctor the risks and benefits of taking this medicine before starting the course.

The usual dosage of Ticlovas 250Mg Tablet recommended to patients is 250 gm, taken with food. Do not take this drug longer than or in more amounts than prescribed by your doctor.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Hematologist before using this medicine.

• Heart Attack

• Unstable Angina

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Hematologist before using this medicine.

• Nausea

• Vomiting

• Diarrhoea

• Decreased White Blood Cell Count

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Hematologist before using this medicine.

• Is It safe with alcohol?

  Interaction with alcohol is unknown. Please consult your doctor.

• Are there any pregnancy warnings?

  Ticlobest 250mg tablet is probably safe to use during pregnancy.
  Animal studies have shown low or no adverse effect on the foetus, however, there are limited human studies. Please consult your doctor.

• Are there any breast-feeding warnings?

  Unknown. Human and animal studies are not available. Please consult your doctor.

• Is it safe to drive while on this medicine?

  There is no data available. Please consult doctor before consuming the drug.

• Does this affect kidney function?

  There is no data available. Please consult doctor before consuming the drug.

• Does this affect liver function?

  There is no data available. Please consult doctor before consuming the drug.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Hematologist before using this medicine.

Below is the list of medicines, which have the same composition, strength and form as Ticlovas 250Mg Tablet , and hence can be used as its substitute.

• Tikleen 250Mg Tablet

  Ipca Laboratories Ltd

• Ticlobest 250Mg Tablet

  Aristo Pharmaceuticals Pvt Ltd

• Ticlogard 250Mg Tablet

  Bayer Pharmaceuticals Pvt Ltd

• Ticlopid 250Mg Tablet

  Cipla Ltd

• Tyklid 250Mg Tablet

  Sanofi India Ltd

• Ticlop 250Mg Tablet

  Zydus Cadila

• Ticlovil 250Mg Tablet

  Vilberry Healthcare Pvt Ltd

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Hematologist before using this medicine.

• Are there any missed dose instructions?

  If you miss a dose of Ticlopidine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Hematologist before using this medicine.

Active metabolite formed after the biotransformation of the primary constituent of this medication causes prevention when it comes to combining with adenosine diphosphate (ADP) to platelet receptor thus weakening ADP moderated activation of glycoprotein GPIIb/IIIa complex.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Hematologist before using this medicine.

Whenever you take more than one medicine, or mix it with certain foods or beverages, you"re at risk of a drug interaction.

test

• Interaction with Medicine

  null

  null

  Heplock 10Iu Injection

  null

  Epsolin 50Mg/2Ml Injection

  null

  null

  null

• Ticlopidiner-Drug Information Portal [Internet].druginfo.nlm.nih.gov 2022 [Cited 10 June 2022].Available from:

  https://druginfo.nlm.nih.gov/drugportal/name/ticlopidine

• Ticlopidine injection,solution-DailyMed [Internet].dailymed.nlm.nih.gov 2022 [Cited 10 June 2022].Available from:

  https://go.drugbank.com/drugs/DB00208